![AMDA ON-THE-GO artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts118/v4/be/2f/80/be2f8096-6884-8bf1-683c-bdb565bead4f/mza_166098237352222416.png/100x100bb.jpg)
FMDA | COVID-19 Impact: Monoclonal Antibody Use in PALTC
AMDA ON-THE-GO
English - February 25, 2021 19:16 - 45 minutes - 42 MB - ★★★★★ - 27 ratingsEducation Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: JAMDA On-The-Go | February, 2021
Special Guests: Corinne Bishop, RN, CRRN, CRNI; Christopher Lemelle, MD, MBA
Hosted by: Diane Sanders-Cepeda, DO, CMD
Join special guests, Christopher Lemelle, MD, MBA; Corinne Bishop, RN, CRRN, CRNI; and our host Diane Sanders-Cepeda, DO, CMD; for this episode of FMDA's Journal Club, COVID-19 Impact: Monoclonal Antibody Use in PALTC.
Our learning objectives for this session were:
Review current perspective and current research related to the use of monoclonal antibodies
Discuss operational considerations when starting this treatment program in PALTC facilities
Describe the challenges and opportunities seen statewide and nationally with the delivery of this treatment in PALTC facilities
Recorded: February 24, 2021